1-Acetyl-3-[1-pyrrolidin-1-yl-1-p-tolyl-meth-(Z)-ylidene]-piperidin-4-one | 1027895-22-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 1-Acetyl-3-[1-pyrrolidin-1-yl-1-p-tolyl-meth-(Z)-ylidene]-piperidin-4-one
• 英文别名: (3Z)-1-acetyl-3-[(4-methylphenyl)-pyrrolidin-1-ylmethylidene]piperidin-4-one
• CAS: 1027895-22-2
• 化学式: C₁₉H₂₄N₂O₂
• 分子量: 312.412
• InChiKey: MPQATGKMNBOODP-ZPHPHTNESA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  23
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  40.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  盐酸胍 、 1-Acetyl-3-[1-pyrrolidin-1-yl-1-p-tolyl-meth-(Z)-ylidene]-piperidin-4-one 在 sodium ethanolate 作用下， 以 乙醇 为溶剂， 反应 3.0h， 以35%的产率得到6-acetyl-2-amino-4-(4-methylphenyl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine
  参考文献：
  名称：

  Novel tetrahydropyrido[4,3-d]pyrimidines as gastric antilesion agents

  摘要：

  A variety of substituted tetrahydropyrido[4,3-d]pyrimidines was prepared and found to possess gastric antilesion against ethanol-induced lesions in rats. The more potent compounds possessed similar activity against aspirin-induced gastric lesions. A selective group of compounds was determined to be inactive as gastric antisecretory agents in rabbit isolated parietal cells. The antilesion properties of these tetrahydropyrido[4,3-d]pyrimidines make them a potential alternative to prostaglandin therapy for gastric antilesion therapy and may have clinical utility in peptic ulcer disease.

  DOI：

  10.1016/0223-5234(92)90085-f
• 作为产物：
  描述：

  N-乙酰基-4-哌啶酮 在 盐酸 、 对甲苯磺酸 、 三乙胺 作用下， 以 二氯甲烷 、 甲苯 、 苯 为溶剂， 反应 15.5h， 生成 1-Acetyl-3-[1-pyrrolidin-1-yl-1-p-tolyl-meth-(Z)-ylidene]-piperidin-4-one
  参考文献：
  名称：

  Novel tetrahydropyrido[4,3-d]pyrimidines as gastric antilesion agents

  摘要：

  A variety of substituted tetrahydropyrido[4,3-d]pyrimidines was prepared and found to possess gastric antilesion against ethanol-induced lesions in rats. The more potent compounds possessed similar activity against aspirin-induced gastric lesions. A selective group of compounds was determined to be inactive as gastric antisecretory agents in rabbit isolated parietal cells. The antilesion properties of these tetrahydropyrido[4,3-d]pyrimidines make them a potential alternative to prostaglandin therapy for gastric antilesion therapy and may have clinical utility in peptic ulcer disease.

  DOI：

  10.1016/0223-5234(92)90085-f

文献信息

• Novel tetrahydropyrido[4,3-d]pyrimidines as gastric antilesion agents
  作者：PJ Sanfilippo、M Urbanski、L Williams、JB Press、LB Katz、DA Shriver、JA Fernandez、D Shatynski、SJ Offord

  DOI：10.1016/0223-5234(92)90085-f

  日期：1992.10

  A variety of substituted tetrahydropyrido[4,3-d]pyrimidines was prepared and found to possess gastric antilesion against ethanol-induced lesions in rats. The more potent compounds possessed similar activity against aspirin-induced gastric lesions. A selective group of compounds was determined to be inactive as gastric antisecretory agents in rabbit isolated parietal cells. The antilesion properties of these tetrahydropyrido[4,3-d]pyrimidines make them a potential alternative to prostaglandin therapy for gastric antilesion therapy and may have clinical utility in peptic ulcer disease.